All 20 US trial sites are now open in the XanaMIA phase 2b/3 trial that is studying oral Xanamem® vs. placebo for 36 weeks, ...

NewAmsterdam will host a live webcast and conference call at 10:00 a.m. ET on July 30, 2025 to review the full AD biomarker data presented at AAIC. The call will include remarks from featured speakers ...

Study harnesses a cell-type-specific, multi-target drug discovery strategy grounded in human data and real-world evidence.

Frontotemporal dementia (FTD) typically develops between the ages of 45 and 64 and is often misdiagnosed, either as a ...

Casting director Mukesh Chhabra lauded Mohit Suri's romantic drama, Saiyaara, calling it a 'celebration' and praising the performances of the lead actors.

Since its release on 18 July, Saiyaara has been making a splash at the box office, becoming the highest-grossing opening ...

As pharmaceutical companies struggle to develop Alzheimer’s treatments, scientists are searching for existing drugs that ...

Lawyers for Harvard and the Trump administration pressed their cases in a Boston courtroom over the government's move to cut ...

Cellular senescence is a process in which the cell cycle becomes permanently arrested, thereby inhibiting cell division, proliferation and growth. Various cellular stresses, such as DNA damage, ...

A nationwide clinical trial is offering renewed hope to thousands of Georgia families affected by Alzheimer’s disease.

Shortly before a highly anticipated public meeting on plans for a sprawling residential development, the developer abruptly ...

Gov. Ned Lamont signed a bill last month intending to prevent out-of-state traffickers from making money on bottle returns.